Oluwarotimi Folorunso, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Racemases and Epimerases | 4 | 2023 | 113 | 1.180 |
Why?
|
| Neocortex | 1 | 2023 | 400 | 0.690 |
Why?
|
| Prosencephalon | 1 | 2021 | 303 | 0.670 |
Why?
|
| Craniocerebral Trauma | 1 | 2023 | 482 | 0.660 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 5 | 2023 | 895 | 0.590 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2021 | 1213 | 0.540 |
Why?
|
| Serine | 3 | 2023 | 828 | 0.500 |
Why?
|
| Nervous System Diseases | 1 | 2023 | 1617 | 0.440 |
Why?
|
| Fibroblast Growth Factors | 4 | 2019 | 879 | 0.340 |
Why?
|
| Mental Health | 1 | 2022 | 2997 | 0.320 |
Why?
|
| Alzheimer Disease | 3 | 2022 | 7988 | 0.240 |
Why?
|
| Peptidomimetics | 2 | 2018 | 34 | 0.210 |
Why?
|
| Plaque, Amyloid | 1 | 2022 | 729 | 0.160 |
Why?
|
| Interneurons | 1 | 2023 | 576 | 0.160 |
Why?
|
| Pyramidal Cells | 1 | 2020 | 363 | 0.160 |
Why?
|
| Astrocytes | 2 | 2022 | 1266 | 0.160 |
Why?
|
| Dendrites | 1 | 2020 | 485 | 0.150 |
Why?
|
| Optic Nerve Injuries | 1 | 2019 | 151 | 0.150 |
Why?
|
| Glutamic Acid | 1 | 2023 | 1167 | 0.150 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2019 | 404 | 0.150 |
Why?
|
| Molecular Probes | 1 | 2018 | 316 | 0.150 |
Why?
|
| Neuronal Plasticity | 3 | 2022 | 1418 | 0.140 |
Why?
|
| Mice | 10 | 2023 | 81045 | 0.140 |
Why?
|
| Animals | 13 | 2023 | 168561 | 0.130 |
Why?
|
| Social Isolation | 1 | 2018 | 363 | 0.130 |
Why?
|
| Amygdala | 1 | 2022 | 1305 | 0.130 |
Why?
|
| Physical Conditioning, Animal | 1 | 2018 | 362 | 0.120 |
Why?
|
| PPAR gamma | 1 | 2017 | 493 | 0.120 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 944 | 0.120 |
Why?
|
| Oligopeptides | 1 | 2018 | 1176 | 0.110 |
Why?
|
| Retinal Diseases | 1 | 2019 | 683 | 0.110 |
Why?
|
| Prefrontal Cortex | 1 | 2023 | 2146 | 0.110 |
Why?
|
| Sodium | 1 | 2018 | 1627 | 0.110 |
Why?
|
| Reperfusion Injury | 1 | 2019 | 1025 | 0.100 |
Why?
|
| Neurons | 2 | 2023 | 9325 | 0.100 |
Why?
|
| Synapses | 1 | 2020 | 1724 | 0.100 |
Why?
|
| Superoxide Dismutase | 1 | 2013 | 596 | 0.100 |
Why?
|
| Brain Injuries | 1 | 2022 | 2024 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 4 | 2021 | 21821 | 0.090 |
Why?
|
| HEK293 Cells | 4 | 2019 | 4200 | 0.080 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 18006 | 0.080 |
Why?
|
| DNA-Binding Proteins | 2 | 2016 | 9639 | 0.070 |
Why?
|
| Mice, Knockout | 5 | 2021 | 14554 | 0.070 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2016 | 1421 | 0.070 |
Why?
|
| Hippocampus | 1 | 2018 | 3661 | 0.060 |
Why?
|
| Synaptic Transmission | 2 | 2022 | 1179 | 0.060 |
Why?
|
| Genome-Wide Association Study | 1 | 2023 | 12220 | 0.060 |
Why?
|
| Amino Acid Transport System ASC | 1 | 2022 | 12 | 0.050 |
Why?
|
| Schizophrenia | 1 | 2021 | 6874 | 0.050 |
Why?
|
| Protein Binding | 3 | 2019 | 9387 | 0.050 |
Why?
|
| Pregnancy | 1 | 2023 | 29087 | 0.050 |
Why?
|
| Sensory Gating | 1 | 2021 | 47 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 12071 | 0.050 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2020 | 112 | 0.050 |
Why?
|
| Leukostasis | 1 | 2019 | 22 | 0.040 |
Why?
|
| Nerve Crush | 1 | 2019 | 79 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2019 | 5180 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2019 | 643 | 0.040 |
Why?
|
| Phosphopeptides | 1 | 2018 | 241 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2019 | 8436 | 0.040 |
Why?
|
| Neuroglia | 1 | 2022 | 925 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 13655 | 0.030 |
Why?
|
| Humans | 10 | 2023 | 742088 | 0.030 |
Why?
|
| Dentate Gyrus | 1 | 2017 | 160 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2018 | 963 | 0.030 |
Why?
|
| Sodium Channels | 1 | 2017 | 349 | 0.030 |
Why?
|
| Social Behavior | 1 | 2021 | 1128 | 0.030 |
Why?
|
| Solubility | 1 | 2016 | 1083 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2018 | 1907 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2019 | 1372 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 9735 | 0.030 |
Why?
|
| Thiazolidinediones | 1 | 2017 | 476 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2013 | 12164 | 0.030 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2013 | 279 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2019 | 1119 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 3133 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2019 | 1144 | 0.030 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2013 | 407 | 0.030 |
Why?
|
| Male | 5 | 2021 | 349538 | 0.030 |
Why?
|
| Evoked Potentials | 1 | 2018 | 1057 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 503 | 0.030 |
Why?
|
| Female | 4 | 2023 | 379592 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2016 | 849 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2016 | 1333 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 2505 | 0.020 |
Why?
|
| tau Proteins | 1 | 2019 | 1860 | 0.020 |
Why?
|
| RNA Interference | 1 | 2018 | 2890 | 0.020 |
Why?
|
| Axons | 1 | 2017 | 1681 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 3504 | 0.020 |
Why?
|
| Autophagy | 1 | 2016 | 1301 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 8300 | 0.020 |
Why?
|
| Tomography, Optical Coherence | 1 | 2019 | 2637 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 10943 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2021 | 6142 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2013 | 1807 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 11363 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2017 | 13814 | 0.020 |
Why?
|
| Age Factors | 1 | 2020 | 18355 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2017 | 3861 | 0.010 |
Why?
|
| Rats | 1 | 2018 | 24265 | 0.010 |
Why?
|
| Proteomics | 1 | 2013 | 3618 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2016 | 19223 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 16665 | 0.010 |
Why?
|
| Mutation | 1 | 2017 | 29717 | 0.010 |
Why?
|